In March 2022, IPEC-Americas Executive Committee approved the creation of a specific working group for Latin America. This group's mission will be to advocate, educate, innovate and develop best practices for pharmaceutical excipients in the region, prioritizing patient safety and drug product efficacy. It will be focused on manufacturers, importers and distributors of pharmaceutical excipients as well as members and drug manufacturers in Latin America. In addition, this group will be able to share and leverage guidance on international guidelines of good practices for pharmaceutical excipients, promote training opportunities and advocacy actions with local authorities and government agencies aimed at harmonizing and adopting international practices for pharmaceutical excipients in the region.